2021 年數碼肝癌峰會進行的全球調查顯示，冠狀病毒病第一波對肝癌治療造成沉重打擊

By PR Newswire on 05 Feb 2021

PR Newswire (www.prnasia.com), a Cision company, is the premier global provider of media monitoring platforms and news distribution services that marketers, corporate communicators and investor relations professionals leverage to engage key audiences. Having pioneered the commercial news distribution industry since 1954, PR Newswire today provides end-to-end solutions to produce, distribute, target and measure text and multimedia content across traditional, digital, mobile and social channels. Combining the world's largest multi-channel content distribution and optimization network with comprehensive workflow tools and platforms, PR Newswire powers the stories of organizations around the world. PR Newswire serves tens of thousands of clients from offices in the Americas, Europe, Middle East, Africa and Asia-Pacific regions.

2021 年數碼肝癌峰會：一項評估冠狀病毒病對肝癌影響的全球調查顯示，該病的篩查、診斷和治療出現延遲，專家為此對肝癌的存活率發出嚴峻的警告。

日內瓦2021年2月5日 /美通社/ -- 民意調查報告的部分問題包括：篩查程序延遲、診斷性成像造影和活組織檢查延遲、可調配至治療肝癌患者的醫生人數減少、手術取消，以及參加臨床試驗的患者人數減少。

由巴塞隆拿醫院診所的巴塞隆拿肝病小組、CIBEREH 和米蘭的 OspedaleMaggiore Policlinico 領導的冠狀病毒病全球肝癌結果 (CERO-19) 調查覆蓋了參與冠狀病毒病疫情第一波的 76 個有大量患者的癌症治療中心，研究發現 87% 的中心修訂了肝癌患者的臨床實務。這些中心遍佈歐洲、北美、南美、非洲和亞洲。